Abstract: The musical instrument tuner includes: a sensor device that is attached to a musical instrument; and an operation device that is able to perform wireless communication mutually with the sensor device, in which the sensor device includes an acceleration sensor that has at least two detection axes, frequency detection means for detecting, as a detected frequency, a frequency of a vibration of musical sound generated through an operation of the musical instrument based on an output from the acceleration sensor, and sensor-side communication means for transmitting transmission information including information regarding the detected frequency to the operation device, and the operation device includes operation-side communication means for receiving the transmission information transmitted from the sensor device, display means, and control means for generating tuning information of the musical instrument and causing the display means to display the tuning information based on the transmission information received

Abstract: The present invention relates to a medicament for treating and/or preventing inflammatory bowel disease, comprising a quinolone compound of the formula shown below as an active ingredient.

Abstract: Oxidized cellulose nanofibers wherein an aqueous dispersion of the oxidized cellulose nanofibers which has undergone concentration adjustment has a retention of a viscosity of 50% or higher measured immediately after 30-minute stirring with Disper at a rotation speed of 1,000 rpm, with respect to the viscosity of the aqueous dispersion of the oxidized cellulose nanofibers measured immediately after the concentration adjustment.

Abstract: The purpose of the present invention is to provide a compound having excellent antibacterial activity against mycobacterium tuberculosis, multidrug-resistant tuberculosis bacteria, and/or non-tuberculous acid-fast bacteria. A compound represented by formula [I]: (in the formula, each symbol is as described in the attached specification), or a salt thereof can be used to diagnose, prevent, and/or treat tuberculosis.

Abstract: The present invention intends to provide an acid type carboxylated cellulose nanofiber having a high viscosity in a low shear region, or to provide an acid type carboxylated cellulose nanofiber having a very short fiber length, and the acid type carboxylated cellulose nanofiber has a carboxy group at least in part of a constituent unit constituting a cellulose molecular chain, wherein a viscosity of water dispersion with a content from 0.95 to 1.05% by mass is 400 Pa·s or higher at a shear velocity from 0.003 to 0.01 s?1 at 30° C., or an average fiber length is from 50 to 500 nm and a ratio of fibers having a fiber length of 300 nm or shorter is 50% or higher.

Abstract: A method for storing chemically modified cellulose fibers, the method characterized by storing chemically modified cellulose fibers in an atmosphere of 0-18° C.

Abstract: An image forming apparatus connected to a charging device includes an image forming unit, a fixing unit, a charge processor, a controller, and a printed sheet counter. The charge processor charges a fee for printing. The controller selects an energy saving mode, upon deciding that a balance of a deposited amount in the charging device is less than a threshold amount. The printed sheet counter counts the number of sheets of the recording medium printed by the image forming unit in one single printing job. The controller selects the energy saving mode for the next printing job, upon deciding that the number of sheets printed in one single printing job is less than a predetermined threshold number of sheets, when the deposit balance is remaining in the charging device.

Abstract: A display device including a display unit including a plurality of light emitting elements, and a control unit that individually controls the plurality of light emitting elements in each of a plurality of main frames according to the gradation data externally input based on output from an external device. The plurality of main frames each include a plurality of sub-frames. The control unit turns on predetermined ones of the plurality of light emitting elements in a predetermined one of the plurality of main frames such that a difference between a gradation value of one or more of the plurality of sub-frames having a maximum gradation value and a gradation value of one or more of the plurality of sub-frames having a minimum gradation value is at least 2.

Abstract: In a predetermined main frame, a display device exerts lighting control on a first LED in a predetermined pixel with a corrected first LED gradation value lower than a first LED gradation value according to gradation data, and exerts lighting control on a second LED included in the predetermined pixel with a second LED gradation value according to gradation data. The predetermined main frame is at least one main frame included in the plurality of main frames. In the predetermined main frame, the first LED gradation value is lower than a first reference value, the second LED gradation value is lower than a second reference value, and a rate of a steady-state period to a whole lighting period in at least one lighting period is smaller than a predetermined value of less than 50% in at least one sub-frame in which lighting control is exerted over the first LED.

Abstract: It is an object of the present invention to provide a compound having an excellent antibacterial activity against tuberculosis bacteria, multidrug-resistant tuberculosis bacteria and/or non-tuberculous mycobacteria. Disclosed is a compound of the general formula (1): wherein each symbol is defined as described in the attached specification, or a salt thereof.

Abstract: An object is to provide an acid-type carboxymethylated cellulose nanofiber in which the viscosity is not excessively high at the time of preparing a dispersion liquid and the introduced carboxymethyl group is desalted to convert the acid type, and the acid-type carboxymethylated cellulose nanofiber has 0.01 to 0.50 of the degree of substitution with carboxymethyl group per glucose unit, wherein the B-type viscosity in an aqueous dispersion with a concentration of 0.95 to 1.05% by mass is 1000 mPa·s or more under the condition of 60 rpm and 20° C., and 7000 mPa·s or more under the condition of 6 rpm and 20° C.

Abstract: An image forming apparatus connected to a charging device includes an image forming unit, a fixing unit, a charge processor, a controller, and a printed sheet counter. The charge processor charges a fee for printing. The controller selects an energy saving mode, upon deciding that a balance of a deposited amount in the charging device is less than a threshold amount. The printed sheet counter counts the number of sheets of the recording medium printed by the image forming unit in one single printing job. The controller selects the energy saving mode for the next printing job, upon deciding that the number of sheets printed in one single printing job is less than a predetermined threshold number of sheets, when the deposit balance is remaining in the charging device.

Abstract: A display apparatus includes a display, a voltage controller, a current driver, and a lighting control circuit. The control by the lighting control circuit is such that one frame is divided into N-pieces of subframes (the N is a natural number equal to or greater than two) which can be displayed at a predetermined frame rate f. In first frame cycle, one frame is divided into M-pieces of virtual subframes (the M is a natural number greater than the N), and N-pieces out of the M-pieces of the virtual subframes are selected as first displayed subframes and displayed on the display. Unselected (M?N) pieces of the virtual subframes are not displayed in the first frame cycle. In second frame cycle subsequent to the first frame cycle, the virtual subframes corresponding to undisplayed virtual subframes in the first frame cycle are selected as second displayed subframes.

Abstract: A display apparatus time-divisionally expresses gradation values allocated to the sub-frames so that the gradation value of the single frame is expressed by a total of the gradation values of the sub-frames. Each of the plurality of sub-frames includes a plurality of weighted elements with different gradation values to express the gradation values by powers of two. A lighting controller performs control such that the weighted elements in at least one of the plurality of sub-frames in one frame are aligned in an order different from an order of the weighted elements in at least one of the plurality of sub-frames in another frame and, of the plurality of weighted elements in at least one of the plurality of sub-frames in the single frame, the weighted element at the end of the timeline turns OFF a corresponding one of the light emitting elements.

Abstract: The purpose of the present invention is to provide a compound having excellent antibacterial activity against mycobacterium tuberculosis, multidrug-resistant tuberculosis bacteria, and/or non-tuberculous acid-fast bacteria. A compound represented by formula [I]: (in the formula, each symbol is as described in the attached specification), or a salt thereof can be used to diagnose, prevent, and/or treat tuberculosis.

Abstract: In a predetermined main frame, a display device exerts lighting control on a first LED in a predetermined pixel with a corrected first LED gradation value lower than a first LED gradation value according to gradation data, and exerts lighting control on a second LED included in the predetermined pixel with a second LED gradation value according to gradation data. The predetermined main frame is at least one main frame included in the plurality of main frames. In the predetermined main frame, the first LED gradation value is lower than a first reference value, the second LED gradation value is lower than a second reference value, and a rate of a steady-state period to a whole lighting period in at least one lighting period is smaller than a predetermined value of less than 50% in at least one sub-frame in which lighting control is exerted over the first LED.

Abstract: Provided is a water storage tank for a washing machine. The water storage tank for the washing machine includes: a tank body configured in a housing of the washing machine, and having a water flowing portion which is internally formed into a tubular shape and constitutes a continuous flow path surface and an external surface portion that constitutes a flexible external surface; a water injecting port arranged at one end of the tank body and configured to inject water, as washing drum drainage water, discharged from a washing drum to the tank body; and a water outtake port arranged at another end of the tank body and capable of recirculating the water injected into the tank body into the washing drum.

Abstract: In a display apparatus having a plurality of light emitting elements, a single frame includes a plurality of sub-frames, each of which includes a plurality of weighted elements with different gradations expressed at powers of two. When the number of sub-frames in a single frame is X (X is an integer greater than 1) and a maximum gradation value that can be expressed in each of the sub-frames is 2Y?1 (Y is an integer greater than 1), and the single frame is expressed by the gradation value in a range of X·2Y-1 to X(2Y?1)?2Y-1, a lighting controller allocates the gradation value to each of the sub-frames so that the weighted element at an end of a timeline of at least one sub-frame of the plurality of sub-frames in the single frame is turned OFF.

Abstract: It is an object of the present invention to provide a compound having an excellent antibacterial activity against tuberculosis bacteria, multidrug-resistant tuberculosis bacteria and/or non-tuberculous mycobacteria. Disclosed is a compound of the general formula (1): wherein each symbol is defined as described in the attached specification, or a salt thereof.

Abstract: It is an object of the present invention to provide a compound having an excellent antibacterial activity against tuberculosis bacteria, multidrug-resistant tuberculosis bacteria and/or non-tuberculous mycobacteria. Disclosed is a compound of the general formula (1): wherein each symbol is defined as described in the attached specification, or a salt thereof.